36 Degradation of type III and IV collagen associates with outcome when measured in serum from patients with metastatic melanoma treated with immune checkpoint inhibitors

• Marco Donia,
• Christina Jensen,
• Nicholas Willumsen,
• Inge Svane,
• Anders Kverneland,
• Morten A Karsdal

Affiliations

Marco Donia

2National Center for Cancer Immune Therapy (CCIT- DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Christina Jensen

1Nordic Bioscience, Herlev, Denmark

Nicholas Willumsen

1Nordic Bioscience, Herlev, Denmark

Inge Svane

2National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Anders Kverneland

2National Center for Cancer Immune Therapy (CCIT-DK), Herlev Hospital, University of Copenhagen, Herlev, Denmark

Morten A Karsdal

1Nordic Bioscience, Herlev, Denmark